An international phase III randomised study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
Trial Number
NCT03278717 (ClinicalTrials.gov Identifier)Contact Person
Status
Closed to Recruitment
Disease Site
Recurrent Maintenance Ovarian
Lead Cooperative Group
Participating Groups
ANZGOG
CCTG